Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignace Vergote

Showing results (181-190 of 578) with videos related to

Pageof 58
Sort By:
Gynecologic Oncology|August 11, 2018
Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancerKathleen N Moore, David M O'Malley, Ignace Vergote, et al.
Cells|February 5, 2020
Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot StudyAnn Vankerckhoven, Roxanne Wouters, Thomas Mathivet, et al.
Translational Oncology|March 26, 2021
Type of chemotherapy has substantial effects on the immune system in ovarian cancerAnn Vankerckhoven, Thaïs Baert, Matteo Riva, et al.
Annals of Surgery|April 13, 2013
Clinical outcome after radical excision of moderate-severe endometriosis with or without bowel resection and reanastomosis: a prospective cohort studyChristel Meuleman, Carl Tomassetti, Albert Wolthuis, et al.
Anticancer Research|October 30, 2016
In Vitro Generation of Murine Dendritic Cells for Cancer Immunotherapy: An Optimized ProtocolThaïs Baert, Abhishek D Garg, Eva Vindevogel, et al.
Journal of the Society for Gynecologic Investigation|February 21, 2003
Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levelsFrédéric Amant, Erik Huys, Anneke Geurts-Moespot, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 5, 2004
A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot studyFrédéric Amant, Cecilia M Dorfling, Jos de Brabanter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2009
Management of surgical stage III and IV endometrioid endometrial carcinoma: an overviewF H van Wijk, M E L van der Burg, Curt W Burger, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 26, 2015
Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of lifeLori Brotto, Michael Brundage, Paul Hoskins, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 3, 2014
Prognostic value of serum HE4 levels and risk of ovarian malignancy algorithm scores at the time of ovarian cancer diagnosisJeroen Kaijser, Vanya Van Belle, Toon Van Gorp, et al.
Pageof 58

Showing results (181-190 of 578) with videos related to

Sort By:
Pageof 58
Gynecologic Oncology|August 11, 2018
Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancerKathleen N Moore, David M O'Malley, Ignace Vergote, et al.
Cells|February 5, 2020
Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot StudyAnn Vankerckhoven, Roxanne Wouters, Thomas Mathivet, et al.
Translational Oncology|March 26, 2021
Type of chemotherapy has substantial effects on the immune system in ovarian cancerAnn Vankerckhoven, Thaïs Baert, Matteo Riva, et al.
Annals of Surgery|April 13, 2013
Clinical outcome after radical excision of moderate-severe endometriosis with or without bowel resection and reanastomosis: a prospective cohort studyChristel Meuleman, Carl Tomassetti, Albert Wolthuis, et al.
Anticancer Research|October 30, 2016
In Vitro Generation of Murine Dendritic Cells for Cancer Immunotherapy: An Optimized ProtocolThaïs Baert, Abhishek D Garg, Eva Vindevogel, et al.
Journal of the Society for Gynecologic Investigation|February 21, 2003
Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levelsFrédéric Amant, Erik Huys, Anneke Geurts-Moespot, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 5, 2004
A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot studyFrédéric Amant, Cecilia M Dorfling, Jos de Brabanter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2009
Management of surgical stage III and IV endometrioid endometrial carcinoma: an overviewF H van Wijk, M E L van der Burg, Curt W Burger, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 26, 2015
Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of lifeLori Brotto, Michael Brundage, Paul Hoskins, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 3, 2014
Prognostic value of serum HE4 levels and risk of ovarian malignancy algorithm scores at the time of ovarian cancer diagnosisJeroen Kaijser, Vanya Van Belle, Toon Van Gorp, et al.
Pageof 58